Under the patronage of the Crown Prince, the Riyadh Biotechnology Summit 2026 kicks off
Under the patronage of His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince, Prime Minister, and Chairman of the Board of Directors of the Riyadh Biotechnology Center Foundation, the Saudi capital is preparing to host the fourth edition of the "Riyadh Global Biotechnology Summit" from September 14 to 16, 2026. This prominent event is organized by the Ministry of National Guard Health Affairs, represented by the King Abdullah International Medical Research Center (KAIMRC), in strategic partnership with the Ministry of Investment.
Commenting on this important event, His Royal Highness Prince Abdullah bin Bandar bin Abdulaziz, Minister of the National Guard and a member of the Board of Directors of the Riyadh Biotechnology Center Foundation, expressed his deepest gratitude to His Royal Highness the Crown Prince for his generous patronage of the summit. His Highness affirmed that this patronage reflects the unwavering support of the wise leadership for the biotechnology sector, recognizing it as a cornerstone of the Kingdom's future economy and healthcare, and empowering the tireless efforts aimed at achieving the objectives of the National Biotechnology Strategy launched by His Royal Highness the Crown Prince.
Strategic dimensions and alignment with Vision 2030
This summit is of exceptional importance given the significant progress being made in Saudi Arabia under Vision 2030, where the biotechnology sector is a key driver for diversifying the national economy away from oil. The summit serves as a practical implementation of the National Biotechnology Strategy, which aims to position the Kingdom as a leading global hub in this field by 2030 and to drive innovation in the Middle East and North Africa region. This strategic direction seeks to enhance pharmaceutical and healthcare security, localize advanced knowledge-based industries, and contribute to improving quality of life and providing innovative medical solutions to contemporary health challenges.
A global platform for innovation and investment
The Riyadh Global Biotechnology Summit is considered one of the most important international platforms, bringing together leading global minds. The fourth edition is expected to see a wide attendance from government leaders, decision-makers, CEOs of major global pharmaceutical companies, as well as international scientists, experts, and investors. The summit sessions will focus on discussing the latest trends in medical biotechnology, including cell and gene therapies, artificial intelligence applications in life sciences, and vaccine development—fields that represent the future of modern medicine.
Sustainable economic and health impact
The summit's significance extends beyond the scientific realm, encompassing a broad economic and developmental impact. Through its partnership with the Ministry of Investment, the summit aims to attract high-quality foreign and domestic investments in the pharmaceutical industry and research and development, thereby bolstering the Kingdom's dynamic economy. These events also contribute to creating high-quality job opportunities for Saudi nationals and transferring advanced knowledge and technology to the Kingdom, further solidifying Riyadh's position as a capital of health innovation and a leading destination for global initiatives in public health and future technologies.
